Equities

Integra Lifesciences Holdings Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert

Integra Lifesciences Holdings Corp

Actions
Health CareMedical Equipment and Services
  • Price (USD)11.32
  • Today's Change0.51 / 4.72%
  • Shares traded707.94k
  • 1 Year change-53.34%
  • Beta1.0167
Data delayed at least 15 minutes, as of Feb 13 2026 21:00 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2024202420232022
ASSETS
Cash And Short Term Investments274309457
Total Receivables, Net272259274
Total Inventory429390325
Prepaid expenses7767107
Other current assets, total3033--
Total current assets1,0821,0581,161
Property, plant & equipment, net550496460
Goodwill, net1,0971,0551,039
Intangibles, net1,2081,0681,127
Long term investments------
Note receivable - long term------
Other long term assets675857
Total assets4,0373,7823,890
LIABILITIES
Accounts payable8392102
Accrued expenses222192173
Notes payable/short-term debt000
Current portion long-term debt/capital leases6071538
Other current liabilities, total108.547.25
Total current liabilities922307321
Total long term debt1,1961,4851,405
Total debt1,8031,5001,443
Deferred income tax613563
Minority interest------
Other liabilities, total313367296
Total liabilities2,4922,1942,085
SHAREHOLDERS EQUITY
Common stock0.920.910.91
Additional paid-in capital1,3231,3021,277
Retained earnings (accumulated deficit)940947879
Treasury stock - common(691)(647)(363)
Unrealized gain (loss)------
Other equity, total(28)(15)10
Total equity1,5451,5881,804
Total liabilities & shareholders' equity4,0373,7823,890
Total common shares outstanding777884
Treasury shares - common primary issue14136.82
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.